Free CME from PeerView


Endocrinology & Diabetes CME

Credits: 0.5 CME
PVI, PeerView Institute for Medical Education
Advances in Pediatric Growth Hormone Therapy: Visualizing the Impact on Individualized Care
Bradley S. Miller, MD, PhD
December 29, 2021
Credits: 1.5 CME / MOC
Penn State College of Medicine
Clinical Colloquia in Retinal Disease: Updating Evidence-Based, Patient-Centered Care for Diabetic Retinopathy
Carl Regillo, MD
November 21, 2021
Domenica M. Rubino, MD /
Credits: 1.0 CME
Medical Learning Institute, Inc.
Gut Feeling: The Increasing Importance of GLP-1–Based Therapies for Personalized Obesity Management
Domenica M. Rubino, MD / Donna H. Ryan, MD, FTOS
November 8, 2021
Credits: 1.00 CME
Medical Learning Institute, Inc.
The Contemporary Use of GLP-1 RAs to Individualize Therapy in T2DM: Candid Conversations on Glycemic and Nonglycemic Effects
James R. Gavin III, MD, PhD
July 27, 2021
Credits: 0.50 CME
Medical Learning Institute, Inc.
Determining Which Patients Will Benefit From GLP-1 RAs: Applying Guidelines and Evidence to Individualize Treatment Decisions in T2DM
Vanita R. Aroda, MD
July 16, 2021
Credits: 0.50 CME
Medical Learning Institute, Inc.
Demystifying the Role of Incretin-Based Weight-Loss Pharmacotherapy: A Patient-Centered Approach to Overcoming Barriers and Addressing Underlying Causes of Obesity
Donna H. Ryan, MD, FTOS
July 15, 2021
Christopher D. Still, DO, FACP, FTOS / Alan C. Wittgrove, MD, FASMBS, FACS
Credits: 1.00 CME
Medical Learning Institute, Inc.
Going With Your Gut: Targeting Long-Term Weight Loss With Current and Emerging Incretin-Based Pharmacotherapy
Christopher D. Still, DO, FACP, FTOS / Alan C. Wittgrove, MD, FASMBS, FACS
July 7, 2021
Credits: 1.00 CME
Penn State College of Medicine
Management of Hyperlipidemia in the Family Medicine Setting: Diagnosis, Management, and the Role of Emerging Lipid-Lowering Therapies
James A. Underberg, MD, MS, FACPM, FACP, FNYAM, FASPC, FNLA
June 22, 2021
Credits: 1.50 CME
Medical Learning Institute, Inc.
Recognizing and Treating Hyperkalemia in Patients With Heart Failure and/or Chronic Kidney Disease: An Update for Hospitalists
George L. Bakris, MD
May 31, 2021
Credits: 1.50 CME / MOC
University of Florida College of Medicine
Lower Is Better: Novel Therapeutic Strategies Targeting PCSK9 for Reducing LDL-C Levels in Patients With Hyperlipidemia and ASCVD
Professor Kausik Ray
May 27, 2021
Credits: 0.50 CME
Medical Learning Institute, Inc.
The Evolving Role of Oxybate Agents in the Management of Narcolepsy: A Visual Exploration of Individualized Care
Richard K. Bogan, MD, FCCP, FAASM
May 18, 2021
Credits: 0.50 CME
Medical Learning Institute, Inc.
Acute Hepatic Porphyria: Disease Diagnosis and Revelations Regarding the Role of siRNA Therapy
Karl E. Anderson, MD
April 15, 2021
Credits: 1.25 CME
Medical Learning Institute, Inc.
Simulation – Partnering With Peers and Patients: Achieving T2DM Treatment Goals With GLP-1 RA Therapy
Jay H. Shubrook, DO, FAAFP, FACOFP
March 31, 2021
Medical Learning Institute, Inc.
A Visual Exploration of New Opportunities in Thyroid Cancer: Targeting RET Alterations to Optimize Outcomes
Marcia S. Brose, MD, PhD
December 30, 2020
Joslin Diabetes Center
Highlighting the Vital Role of Primary Care in Identifying and Optimizing the Treatment of Diabetic Retinopathy and Diabetic Macular Edema
Andrew Moshfeghi, MD, MBA
November 18, 2020
Penn State College of Medicine
Show Me the Data: Improving Renal Outcomes With Glucose-Lowering Therapy in the Individualized Management of T2DM
George L. Bakris, MD
November 2, 2020
PeerView Institute
The Art of Medicine: Creating Treatment Regimens With GLP-1 RAs to Reduce Cardiovascular Risks in Patients With T2DM
Lucia M. Novak, MSN, ANP-BC, BC-ADM, CDTC
October 28, 2020
Medical Learning Institute, Inc.
Leveraging the Tools at Hand: Current Perspectives on Weight-Loss Pharmacotherapy for Obesity Management
Ken Fujioka, MD
September 23, 2020
Penn State College of Medicine
Complex Cases in Contemporary Practice: Applying New Evidence for SGLT2 Inhibitors in the Management of Patients With Comorbid Cardiometabolic Diseases
John B. Buse, MD, PhD
July 24, 2020
Medical Learning Institute, Inc.
Test Your Knowledge: Current Guidance on GLP-1 Receptor Agonists to Individualize Treatment for T2DM
Vanita R. Aroda, MD
June 25, 2020
Medical Learning Institute, Inc.
Go Get the Glucagon! Current and Emerging Options for Treating Severe Hypoglycemia
Pablo F. Mora, MD, FACE, CDE
March 13, 2020

Upcoming Live Events

Education Collections

Recent CME Podcast

More Podcasts from PeerView